Applovin leads, up 9.3%, while Regeneron is the biggest loser, down 3.6%

From Nasdaq: 2025-03-12 10:53:06

In early trading, Applovin leads Nasdaq 100, up 9.3% while Regeneron Pharmaceuticals is the biggest loser, down 3.6%. Year to date, Applovin has lost 13.0% and Regeneron is down 2.9%.

T-Mobile US is down 2.8% and Tesla is up 8.5% today, making significant moves in the market. These are the top performers in the Nasdaq 100 index.



Read more at Nasdaq: Nasdaq 100 Movers: REGN, APP